Works matching Parkinson's disease treatment

Results: 4535

Cost-Effectiveness Analysis of Dopamine Agonists in the Treatment of Parkinson's Disease in Japan.

Published in:

PharmacoEconomics, 2001, v. 19, p. 875, doi. 10.2165/00019053-200119080-00009

By:

Shimbo, T.;
Hira, K.;
Takemura, M.;
Fukui, T.

Publication type:

Article

The Concept of Continuous Dopaminergic Stimulation: What We Should Consider when Starting Parkinson’s Disease Treatment.

Published in:

Neurodegenerative Diseases, 2010, v. 7, n. 1-3, p. 213, doi. 10.1159/000295667

By:

Stocchi, Fabrizio

Publication type:

Article

Levodopa/carbidopa/entacapone for the treatment of early Parkinson's disease: a meta-analysis.

Published in:

Neurological Sciences, 2020, v. 41, n. 8, p. 2045, doi. 10.1007/s10072-020-04303-x

By:

Liao, Xiaoli;
Wu, Nianyue;
Liu, Dongfeng;
Shuai, Bowei;
Li, Shilei;
Li, Ke

Publication type:

Article

Safety of selegiline (deprenyl) in the treatment of Parkinson's disease.

Published in:

1998

By:

Heinonen, E.H.;
Myllylä, V.;
Myllylä, V

Publication type:

journal article

Dopamine D Receptor Agonists: The Way Forward for the Treatment of Parkinson's Disease?

Published in:

CNS Drugs, 1999, v. 11, n. 2, p. 83, doi. 10.2165/00023210-199911020-00001

By:

Vermeulen, R.J.;
Drukarch, B.;
Wolters, E.C.;
Stoof, J.C.

Publication type:

Article

The Significance of Continuous Dopaminergic Stimulation in the Treatment of Parkinson's Disease.

Published in:

Drugs, 1998, v. 55, n. 1, p. 1, doi. 10.2165/00003495-199855001-00001

By:

Chase, T.N.

Publication type:

Article

Tremor-Predominant Parkinson's Disease: Approaches To Treatment.

Published in:

Drugs & Aging, 2000, v. 16, n. 4, p. 273, doi. 10.2165/00002512-200016040-00003

By:

Marjama-Lyons, J.;
Koller, W.

Publication type:

Article

Is NADH Effective in the Treatment of Parkinson's Disease?

Published in:

Drugs & Aging, 1998, v. 13, n. 4, p. 263, doi. 10.2165/00002512-199813040-00002

By:

Swerdlow, R.H.

Publication type:

Article

Dopamine D Receptors: Relevance for the Drug Treatment of Parkinson's Disease.

Published in:

CNS Drugs, 1999, v. 12, n. 5, p. 391, doi. 10.2165/00023210-199912050-00006

By:

Levant, B.;
Ling, Z.D.;
Carvey, P.M.

Publication type:

Article

Computational approaches for understanding the diagnosis and treatment of Parkinson's disease.

Published in:

IET Systems Biology (Wiley-Blackwell), 2015, v. 9, n. 6, p. 226, doi. 10.1049/iet-syb.2015.0030

By:

Smith, Stephen L.;
Lones, Michael A.;
Bedder, Matthew;
Alty, Jane E.;
Cosgrove, Jeremy;
Maguire, Richard J.;
Pownall, Mary Elizabeth;
Ivanoiu, Diana;
Lyle, Camille;
Cording, Amy;
Elliott, Christopher J.H.

Publication type:

Article

Validation of the OPTIMIPARK Questionnaire: A Tool to Optimize Treatment in Parkinson's Disease.

Published in:

Movement Disorders Clinical Practice, 2022, v. 9, n. 8, p. 1085, doi. 10.1002/mdc3.13581

By:

Máñez‐Miró, Jorge U.;
Vivancos‐Matellano, Francisco;
Alonso‐Frech, Fernando;
Vela‐Desojo, Lydia;
López‐Ariztegui, Nuria;
López‐Manzanares, Lydia;
Balaguer, Ernest;
Martínez‐Castrillo, Juan Carlos;
Herrero‐Infante, Yolanda;
Gasca‐Salas, Carmen;
Morales‐Casado, María Isabel;
Casas, Elena;
Hernández, Antonio;
Pareés, Isabel;
Tegel‐Ayuela, Iciar;
Martínez‐Fernández, Raul;
Martinez‐Martin, Pablo

Publication type:

Article

Diagnóstico y tratamiento médico de la enfermedad de Parkinson.

Published in:

Revista Cubana de Neurología y Neurocirugía, 2020, v. 10, n. 1, p. 1

By:

Rodríguez García, Pedro Luis

Publication type:

Article

Cost analysis of ropinirole versus levodopa in the treatment of Parkinson's disease.

Published in:

2003

By:

Iskedjian, M.;
Einarson, T.R.;
Iskedjian, Michael;
Einarson, Thomas R

Publication type:

journal article

Cost effectiveness of treatment of Parkinson's disease with entacapone in the United States.

Published in:

2002

By:

Palmer, C.S.;
Nuijten, M.J.C.;
Schmier, J.K.;
Subedi, P.;
Snyder, E.H.;
Palmer, Cynthia S;
Nuijten, Mark J C;
Schmier, Jordana K;
Subedi, Prasun;
Snyder, Edward H

Publication type:

journal article

Treatment of psychosis in Parkinson's disease: safety considerations.

Published in:

2003

By:

Fernandez, Hubert H.;
Trieschmann, Martha E.;
Friedman, Joseph H.

Publication type:

journal article

Cabergoline: A Review of its Use in the Treatment of Parkinson's Disease.

Published in:

Drugs, 2004, v. 64, n. 18, p. 2125, doi. 10.2165/00003495-200464180-00015

By:

Curran, Monique P.;
Perry, Caroline M.

Publication type:

Article

Emerging Therapies in the Pharmacological Treatment of Parkinson’s Disease.

Published in:

Drugs, 2002, v. 62, n. 5, p. 775, doi. 10.2165/00003495-200262050-00005

By:

Korczyn, A.D.;
Nussbaum, M.

Publication type:

Article

Early Treatment of Parkinson's Disease with Cabergoline Delays the Onset of Motor Complications: Results of a Double-Blind Levodopa Controlled Trial.

Published in:

Drugs, 1998, v. 55, n. 1, p. 23, doi. 10.2165/00003495-199855001-00004

By:

Rinne, U.K.;
Bracco, F.;
Chouza, C.;
Dupont, E.;
Gershanik, O.;
Masso, J.F.M.;
Montastruc, J.L.;
Marsden, C.D.

Publication type:

Article

Galantamine-Memantine Combination in the Treatment of Parkinson's Disease Dementia.

Published in:

Brain Sciences (2076-3425), 2024, v. 14, n. 12, p. 1163, doi. 10.3390/brainsci14121163

By:

Frost, Emma D.;
Shi, Swanny X.;
Byroju, Vishnu V.;
Pitton Rissardo, Jamir;
Donlon, Jack;
Vigilante, Nicholas;
Murray, Briana P.;
Walker, Ian M.;
McGarry, Andrew;
Ferraro, Thomas N.;
Hanafy, Khalid A.;
Echeverria, Valentina;
Mitrev, Ludmil;
Kling, Mitchel A.;
Krishnaiah, Balaji;
Lovejoy, David B.;
Rahman, Shafiqur;
Stone, Trevor W.;
Koola, Maju Mathew

Publication type:

Article

Cabergoline: A Review of its Efficacy in the Treatment of Parkinson's Disease.

Published in:

CNS Drugs, 1999, v. 12, n. 6, p. 485

By:

Wiseman, L.R.;
Fitton, A.

Publication type:

Article

Evaluation of Simvastatin as a Disease-Modifying Treatment for Patients With Parkinson Disease: A Randomized Clinical Trial.

Published in:

JAMA Neurology, 2022, v. 79, n. 12, p. 1232, doi. 10.1001/jamaneurol.2022.3718

By:

Stevens, Kara N.;
Creanor, Siobhan;
Jeffery, Alison;
Whone, Alan;
Zajicek, John;
Foggo, Andy;
Jones, Ben;
Chapman, Rebecca;
Cocking, Laura;
Wilks, Jonny;
Webb, Doug;
Carroll, Camille

Publication type:

Article

Ambroxol for the Treatment of Patients With Parkinson Disease With and Without Glucocerebrosidase Gene Mutations: A Nonrandomized, Noncontrolled Trial.

Published in:

JAMA Neurology, 2020, v. 77, n. 4, p. 427, doi. 10.1001/jamaneurol.2019.4611

By:

Mullin, Stephen;
Smith, Laura;
Lee, Katherine;
D'Souza, Gayle;
Woodgate, Philip;
Elflein, Josh;
Hällqvist, Jenny;
Toffoli, Marco;
Streeter, Adam;
Hosking, Joanne;
Heywood, Wendy E.;
Khengar, Rajeshree;
Campbell, Philip;
Hehir, Jason;
Cable, Sarah;
Mills, Kevin;
Zetterberg, Henrik;
Limousin, Patricia;
Libri, Vincenzo;
Foltynie, Tom

Publication type:

Article

Dopaminergic Pathway Genes Influence Adverse Events Related to Dopaminergic Treatment in Parkinson's Disease.

Published in:

Frontiers in Pharmacology, 2019, p. N.PAG, doi. 10.3389/fphar.2019.00008

By:

Redenšek, Sara;
Flisar, Dušan;
Kojović, Maja;
Gregorič Kramberger, Milica;
Georgiev, Dejan;
Pirtošek, Zvezdan;
Trošt, Maja;
Dolžan, Vita

Publication type:

Article

Long-term effects of Lee Silverman Voice Treatment on daily voice use in Parkinson's disease as measured with a portable voice accumulator.

Published in:

Logopedics Phoniatrics Vocology, 2019, v. 44, n. 3, p. 124, doi. 10.1080/14015439.2018.1435718

By:

Körner Gustafsson, Joakim;
Södersten, Maria;
Ternström, Sten;
Schalling, Ellika

Publication type:

Article

Effect of intensive voice treatment on tone-language speakers with Parkinson's disease.

Published in:

Clinical Linguistics & Phonetics, 2007, v. 21, n. 11/12, p. 919, doi. 10.1080/02699200701602045

By:

Whitehill, Tara L.;
Wong, Lina L‐N.

Publication type:

Article

Meta-analysis of the efficacy of acupuncture and moxibustion in the treatment of non-motor symptoms of Parkinson's disease.

Published in:

Neural Computing & Applications, 2023, v. 35, n. 3, p. 2089, doi. 10.1007/s00521-022-07198-1

By:

Huang, Guoli;
Guo, Mingang

Publication type:

Article

Differences in Parkinson's disease treatment between neurology and other departments in Japan.

Published in:

Neurology & Clinical Neuroscience, 2023, v. 11, n. 2, p. 79, doi. 10.1111/ncn3.12699

By:

Tsuboi, Yoshio;
Wada‐Isoe, Kenji;
Kondo, Hiroyuki;
Kojima, Yoshitsugu;
Takeshima, Tomomi;
Iwasaki, Kosuke

Publication type:

Article

Amantadine Revisited: A Contender for Initial Treatment in Parkinson's Disease?

Published in:

2021

By:

Marmol, Sarah;
Feldman, Matthew;
Singer, Carlos;
Margolesky, Jason

Publication type:

journal article

How medical technology can support health care management - Introduction of a telemedicine-based integrated care management, for improved diagnosis and treatment in Parkinson's disease through intersectoral and interdisciplinary collaboration.

Published in:

2017

By:

Dröschel, Daniel;
Walzer, Stefan;
Wilpshaar, Gertjan;
Lynch, Peter

Publication type:

Abstract

A Review of Levodopa Formulations for the Treatment of Parkinson's Disease Available in the United States.

Published in:

Journal of Pharmacy Practice, 2024, v. 37, n. 2, p. 485, doi. 10.1177/08971900221151194

By:

Livingston, Clare;
Monroe-Duprey, Laura

Publication type:

Article

帕金森病的药物治疗研究进展.

Published in:

2025

By:

冯薇;
梁燕

Publication type:

Literature Review

盐酸普拉克索缓释片联合多巴丝肼片治疗帕金森病的疗效及安全性.

Published in:

Evaluation & Analysis of Drug-Use in Hospitals of China / Zhongguo Yiyuan Yongyao Pingjia yu Fenxi, 2018, v. 18, n. 5, p. 644, doi. 10.14009/j.issn.1672-2124.2018.05.026

By:

赵真真;
王丽艳;
刘佳

Publication type:

Article

盐酸普拉克索联合常规治疗对帕金森病合并2型糖尿病的疗效观察.

Published in:

Evaluation & Analysis of Drug-Use in Hospitals of China / Zhongguo Yiyuan Yongyao Pingjia yu Fenxi, 2016, v. 16, n. 11, p. 1501, doi. 10.14009/j.issn.1672-2124.2016.11.021

By:

刘军;
张丽

Publication type:

Article

A 型肉毒毒素耳后注射治疗帕金森病合并神经性耳鸣患者的疗效探讨.

Published in:

Progress in Modern Biomedicine, 2023, v. 23, n. 7, p. 1329, doi. 10.13241/j.cnki.pmb.2023.07.025

By:

李瀛;
罗颜;
卫红齐;
李文全;
罗蔚锋

Publication type:

Article

Cost-effectiveness analysis of dopamine agonists in the treatment of Parkinson's disease in Japan.

Published in:

2001

By:

Shimbo, T;
Hira, K;
Takemura, M;
Fukui, T

Publication type:

journal article

Targeting ferroptosis with the lipoxygenase inhibitor PTC-041 as a therapeutic strategy for the treatment of Parkinson's disease.

Published in:

PLoS ONE, 2024, v. 19, n. 9, p. 1, doi. 10.1371/journal.pone.0309893

By:

Minnella, Angela;
McCusker, Kevin P.;
Amagata, Akiko;
Trias, Beatrice;
Weetall, Marla;
Latham, Joey C.;
O'Neill, Sloane;
Wyse, Richard K.;
Klein, Matthew B.;
Trimmer, Jeffrey K.

Publication type:

Article

Unilateral subthalamotomy in the treatment of Parkinson's disease.

Published in:

2003

By:

Patel NK;
Heywood P;
O'Sullivan K;
McCarter R;
Love S;
Gill SS;
Patel, Nikunj K;
Heywood, Peter;
O'Sullivan, Karen;
McCarter, Renée;
Love, Seth;
Gill, Steven S

Publication type:

journal article

Unilateral subthalamotomy in the treatment of Parkinson’s disease.

Published in:

Brain: A Journal of Neurology, 2003, v. 126, n. 5, p. 1136, doi. 10.1093/brain/awg111

By:

Nikunj K. Patel;
Peter Heywood;
Karen O’Sullivan;
Renée McCarter;
Seth Love;
Steven S. Gill

Publication type:

Article

Deep Brain Stimulation of the Subthalamic Nucleus vs. Globus Pallidus Internus in the Treatment of Parkinson's Disease: A Systematic Review.

Published in:

QJM: An International Journal of Medicine, 2024, v. 117, p. i153, doi. 10.1093/qjmed/hcae070.352

By:

Naguib Al Shehaby, Amr Mohamed;
Kotb, Mohamed Mostafa;
Abdel-Latif, Assem Mounir M.;
Mohamed Abdelaziz, Abdelaziz Mahdy

Publication type:

Article

New strategies for the treatment of Parkinson's disease hold considerable promise for the future management of neurodegenerative disorders.

Published in:

Biogerontology, 2001, v. 2, n. 3, p. 193, doi. 10.1023/A:1011565207964

By:

Bjarkam, Carsten R.;
Sørensen, Jens Chr.;
Sunde, Niels Å.;
Geneser, Finn A.;
Østergaard, Karen

Publication type:

Article

Comparative effectiveness of dopamine agonists and monoamine oxidase type-B inhibitors for Parkinson's disease: a multiple treatment comparison meta-analysis.

Published in:

European Journal of Clinical Pharmacology, 2020, v. 76, n. 12, p. 1731, doi. 10.1007/s00228-020-02961-6

By:

Binde, Caroline D.;
Tvete, Ingunn F.;
Gåsemyr, Jørund I.;
Natvig, Bent;
Klemp, Marianne

Publication type:

Article

Tolerability and safety of ropinirole versus other dopamine agonists and levodopa in the treatment of Parkinson's disease: meta-analysis of randomized controlled trials.

Published in:

2010

By:

Kulisevsky J;
Pagonabarraga J;
Kulisevsky, Jaime;
Pagonabarraga, Javier

Publication type:

journal article

Effects of physician visit frequency for Parkinson's disease treatment on mortality, hospitalization, and costs: a retrospective cohort study.

Published in:

2021

By:

Fujita, Takako;
Babazono, Akira;
Kim, Sung-a;
Jamal, Aziz;
Li, Yunfei

Publication type:

journal article

Effect of Subthalamic Nuclei Electrical Stimulation in the Treatment of Parkinson's Disease.

Published in:

Cell Biochemistry & Biophysics, 2015, v. 71, n. 1, p. 113, doi. 10.1007/s12013-014-0169-0

By:

Tao, Yingqun;
Liang, Guobiao

Publication type:

Article

Expert consensus on diagnosis and treatment of depression in Parkinson's disease with integrated traditional Chinese and Western medicine (2021 edition).

Published in:

Chinese Journal of Contemporary Neurology & Neurosurgery, 2021, v. 21, n. 12, p. 1027, doi. 10.3969/j.issn.1672-6731.2021.12.002

By:

YANG Ning;
LIU Wei-guo;
NING Hou-xu;
LIU Zhen-guo;
XU Li-gang;
ZHANG Jian-bin

Publication type:

Article

Rasagiline A Review of its Use in the Treatment of Idiopathic Parkinson's Disease.

Published in:

2012

By:

Hoy, Sheridan M.;
Keating, Gillian M.

Publication type:

Journal Article

Clinical Features, Pathophysiology, and Treatment of Levodopa-Induced Dyskinesias in Parkinson's Disease.

Published in:

Parkinson's Disease (20420080), 2012, p. 1, doi. 10.1155/2012/943159

By:

Guridi, J.;
González-Redondo, R.;
Obeso, J. A.

Publication type:

Article

Retraction statement: treatment of articulatory dysfunction in Parkinson's disease using repetitive transcranial magnetic stimulation.

Published in:: European Journal of Neurology, 2013, v. 20, n. 11, p. 1497, doi. 10.1111/ene.12276
Publication type:: Article

外泌体及间充质干细胞源性外泌体在帕金森病诊治中的未来.

Published in:

Chinese Journal of Tissue Engineering Research / Zhongguo Zuzhi Gongcheng Yanjiu, 2022, v. 26, n. 25, p. 4076, doi. 10.12307/2022.417

By:

卫宇帆;
樊飞燕;
李双利;
张运克

Publication type:

Article

An update on pathogenesis and clinical scenario for Parkinson's disease: diagnosis and treatment.

Published in:

3 Biotech, 2023, v. 13, n. 5, p. 1, doi. 10.1007/s13205-023-03553-8

By:

Adam, Hussaini;
Gopinath, Subash C. B.;
Md Arshad, M. K.;
Adam, Tijjani;
Parmin, N. A.;
Husein, Irzaman;
Hashim, Uda

Publication type:

Article